ATG7 and neuroblastoma: It has been shown that downregulation of ATG7 can compensate the loss of mitochondria in PTEN-induced kinase 1 (PINK1) deficient dopaminergic human neuroblastoma cells, likely supporting the potential role of ATG7 in PINK1 mutation-related familial Parkinson’s disease (Dagda et al., 2009).